How to Help Your Patients Find Qbrexza in Stock: A Provider's Guide

You've diagnosed a patient with primary axillary hyperhidrosis and determined that Qbrexza (glycopyrronium cloth, 2.4%) is the appropriate treatment. You write the prescription. But two days later, your office gets a call: the patient can't find it at any pharmacy, or their insurance won't cover it, or they've been quoted nearly $900 out of pocket.

This is a common scenario. Qbrexza is a brand-name-only specialty medication with a complex dispensing landscape. Understanding how to guide patients through it — proactively, before the prescription fails — can meaningfully improve treatment adherence and patient outcomes. This guide gives you a practical toolkit for doing exactly that.

Set Patient Expectations Before They Leave Your Office

The single most impactful step you can take is a brief conversation — or a printed handout — before the patient leaves. Key points to cover:

• Qbrexza is not stocked at every pharmacy. They may need to call ahead or use a specific pharmacy network.
• The Journey Total Access Program can reduce cost to $0–$50 for commercially insured patients at in-network pharmacies.
• The pharmacy locator at getqbrexza.com helps find in-network pharmacies.
• If the first pharmacy doesn't have it, most can special-order within 1–3 business days.

Use E-Prescribing to Send to the Right Pharmacy

When e-prescribing Qbrexza, consider routing the prescription to a pharmacy you know participates in the Journey Total Access Program. You can reference the locator at getqbrexza.com prior to prescribing and ask the patient which participating pharmacy is most convenient for them. Some in-network pharmacies offer shipping, which can be especially helpful for patients in rural areas or those with limited mobility.

Understanding the Journey Total Access Program

The Journey Total Access Program has two tiers that work differently depending on where the patient fills their prescription:

1. In-network pharmacies: No savings card required. Commercially insured patients pay as little as $0 (insurance covers Qbrexza) or no more than $50 (insurance does not cover Qbrexza). This is the most favorable option and should be the default recommendation.
2. Out-of-network pharmacies: The Qbrexza Patient Savings Card (downloadable at getqbrexza.com) may allow commercially insured patients whose insurance covers Qbrexza to pay as little as $0. However, if their insurance does not cover Qbrexza at all, cash coupon pricing (~$630–$939) may be the only option.

These programs are not available to patients enrolled in Medicare, Medicaid, TRICARE, VA, or any other federal or state government healthcare program.

Handling Prior Authorization Efficiently

Prior authorization is required by many commercial plans for Qbrexza. To streamline the PA process:

• Document the diagnosis specifically as primary axillary hyperhidrosis (ICD-10: L74.510), not just general hyperhidrosis
• Record HDSS score or equivalent severity measure in the chart note
• Document failed or inadequate response to aluminum chloride prescription antiperspirant, if applicable (step therapy is commonly required)
• Include quality-of-life language in the clinical note: impact on work, social interactions, or daily activities
• Have your MA call Journey Medical patient support (1-855-531-1859) — they can provide plan-specific PA forms and track submission status

Recommend medfinder for Patients Who Can't Locate Stock

For patients who have already tried the pharmacy locator and are still having difficulty, medfinder is a service that calls pharmacies near the patient and checks real-time availability. The patient provides their medication, dosage, and ZIP code; medfinder contacts pharmacies; and results are texted back to the patient. This eliminates the back-and-forth of calling pharmacy after pharmacy — which is often the breaking point where patients abandon a fill.

When to Consider Alternatives

There are several clinical scenarios where pivoting to an alternative is the right move rather than continuing to troubleshoot Qbrexza access:

• Patient is on Medicare or Medicaid with no coverage pathway and cannot afford $630+/month out of pocket
• Insurance PA denial upheld after appeal and patient does not qualify for assistance programs
• Patient experienced intolerable anticholinergic side effects (severe dry mouth, urinary retention) with Qbrexza
• Patient has contraindications to Qbrexza (glaucoma, myasthenia gravis, severe ulcerative colitis, Sjogren's syndrome)

In these cases, Sofdra (sofpironium gel), Botox injections, or Drysol (aluminum chloride) may be more appropriate. See our provider guide on Qbrexza alternatives for a full clinical comparison.

Sample Patient Handout Text

Consider providing patients with a short printed resource at checkout. Here is sample language you can adapt:

"Your Qbrexza prescription has been sent to your pharmacy. If they tell you it's out of stock or they don't carry it, here's what to do: (1) Use the pharmacy locator at getqbrexza.com to find an in-network pharmacy near you where cost may be reduced to $0–$50. (2) Use medfinder.com — they'll call pharmacies near you to find who has it in stock. (3) Call Journey Medical patient support at 1-855-531-1859 for additional help. Do not give up — your medication is available."

For a clinical overview of Qbrexza access issues, see our guide: Qbrexza Availability: What Providers Need to Know in 2026.